Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Inventory (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Inventory for 2 consecutive years, with $74.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 119.68% to $74.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.8 million, a 119.68% increase, with the full-year FY2025 number at $74.8 million, up 119.68% from a year prior.
  • Inventory was $74.8 million for Q4 2025 at Madrigal Pharmaceuticals, up from $69.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $74.8 million in Q4 2025 to a low of $854000.0 in Q1 2024.